Clinical Trial

The IVO-LUNG Study

Name: The IVO-LUNG Study — clinical trial record (NCT07204548)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IVO Lung

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This Phase II, open-label, single-arm study evaluates the efficacy and safety of one-year Ivonescimab consolidation therapy in patients with unresectable Stage III NSCLC who have not progressed after definitive chemoradiotherapy.

Trial Details

NCT Number	NCT07204548
Lead Sponsor	Sun Yat-sen University
Conditions	Non Small Cell Lung Cancer (Stage III)
Enrollment	63 participants
Start Date	2025-10
Primary Completion	2027-10 (estimated)
Study Completion	2029-10 (estimated)
Updated on ClinicalTrials.gov	2025-10-02